Chemical activators of Olr1111 can engage various intracellular signaling cascades that ultimately result in the protein's activation. Forskolin, for example, is a potent activator of adenylate cyclase, which catalyzes the conversion of ATP to cyclic AMP (cAMP). Elevated levels of cAMP can then activate protein kinase A (PKA), a kinase that phosphorylates diverse cellular substrates, including potentially Olr1111. Similarly, IBMX functions by inhibiting phosphodiesterases that degrade cAMP, thereby sustaining an enhanced cAMP concentration that activates PKA, which can also lead to the phosphorylation and activation of Olr1111. Another chemical, PMA, directly activates protein kinase C (PKC), which is known to phosphorylate a wide range of target proteins; this activation cascade can include the phosphorylation of Olr1111.
Ionomycin works by increasing intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases, upon activation, can phosphorylate target proteins like Olr1111. Thapsigargin, by inhibiting SERCA, similarly elevates cytosolic calcium levels, triggering a cascade that can lead to Olr1111 activation through calcium-responsive kinases. A23187, a calcium ionophore, and BAY K8644, which stimulates calcium channels, both raise intracellular calcium, offering another route for the activation of calcium-dependent kinases that could phosphorylate Olr1111. Nitrendipine, by blocking calcium channels, can lead to altered cellular signaling and compensatory activation of kinases that activate Olr1111. Isoproterenol, a beta-adrenergic agonist, increases cAMP production, which activates PKA and can lead to Olr1111 activation. Phosphatidic acid, implicated in mTOR signaling, can activate downstream kinases that target Olr1111. Arachidonic acid, through its metabolites, can initiate diverse kinase signaling cascades, potentially resulting in Olr1111 phosphorylation and activation. Finally, zinc can modulate various signaling pathways, including those involving kinases that may phosphorylate and activate Olr1111.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Inhibits phosphodiesterases, preventing cAMP degradation, which results in increased cAMP levels that activate PKA, potentially leading to the activation of Olr1111. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Directly activates protein kinase C (PKC), which then might phosphorylate and activate Olr1111. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium concentration, which can activate calcium-dependent protein kinases that may phosphorylate and activate Olr1111. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels and activation of calcium-dependent kinases that could phosphorylate and activate Olr1111. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Ionophore that increases intracellular calcium concentration, potentially activating calcium-dependent kinases that might phosphorylate and activate Olr1111. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
Stimulates voltage-dependent L-type calcium channels, leading to an influx of calcium ions, which can activate calcium-dependent kinases capable of phosphorylating and activating Olr1111. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $107.00 $157.00 $449.00 | 6 | |
Blocks L-type calcium channels, leading to altered cellular signaling and compensatory mechanisms that might result in the activation of kinases that phosphorylate and activate Olr1111. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Agonist for beta-adrenergic receptors, leading to increased production of cAMP and activation of PKA, which might subsequently phosphorylate and activate Olr1111. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $104.00 $239.00 $409.00 | ||
Acts as a second messenger that can activate mTOR signaling, potentially leading to kinase activation that might phosphorylate and activate Olr1111. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $90.00 $235.00 $4243.00 | 9 | |
Precursor for eicosanoids and activates multiple signaling pathways, including those involving protein kinases that can phosphorylate and lead to the activation of Olr1111. | ||||||